Find Oxycodone Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 124-90-3, Oxycodone hcl, Oxecta, Oxycontin, Endocodone, Roxicodone
Molecular Formula
C18H22ClNO4
Molecular Weight
351.8  g/mol
InChI Key
MUZQPDBAOYKNLO-RKXJKUSZSA-N
FDA UNII
C1ENJ2TE6C

Oxycodone Hydrochloride
A semisynthetic derivative of CODEINE.
1 2D Structure

Oxycodone Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride
2.1.2 InChI
InChI=1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1
2.1.3 InChI Key
MUZQPDBAOYKNLO-RKXJKUSZSA-N
2.1.4 Canonical SMILES
CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl
2.1.5 Isomeric SMILES
CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O.Cl
2.2 Other Identifiers
2.2.1 UNII
C1ENJ2TE6C
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dihydrohydroxycodeinone

2. Dihydrone

3. Dinarkon

4. Eucodal

5. Oxiconum

6. Oxycodeinon

7. Oxycodone

8. Oxycone

9. Oxycontin

10. Pancodine

11. Theocodin

2.3.2 Depositor-Supplied Synonyms

1. 124-90-3

2. Oxycodone Hcl

3. Oxecta

4. Oxycontin

5. Endocodone

6. Roxicodone

7. Oxycodone Hydrochloride Cii

8. Chebi:7859

9. 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

10. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride

11. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydron;chloride

12. Roxicodone (tn)

13. Oxycontin (tn)

14. (4r,4as,7ar,12bs)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride

15. Oxecta (tn)

16. Roxybond

17. Oxycodone Monohydrochloride

18. Schembl30095

19. Oxycodone Hydrochloride (usp)

20. Chembl1200890

21. Dtxsid80924674

22. Oxycodone Hydrochloride [mi]

23. Oxycodone Hydrochloride [usan]

24. Akos024457896

25. Oxycodone Hydrochloride [mart.]

26. Oxycodone Hydrochloride [vandf]

27. Anhydrous Oxycodone Hydrochloride

28. Oxycodone Hydrochloride [who-dd]

29. Oxycodone Hydrochloride, Analytical Standard

30. Oxycodone Hydrochloride [orange Book]

31. Oxycodone Hydrochloride Cii [usp-rs]

32. Oxycodone Hydrochloride [ep Monograph]

33. Tylox Component Oxycodone Hydrochloride

34. C08026

35. Codoxy Component Oxycodone Hydrochloride

36. D00847

37. Oxycet Component Oxycodone Hydrochloride

38. Oxycodone Hydrochloride [usp Monograph]

39. Roxicet Component Oxycodone Hydrochloride

40. Roxilox Component Oxycodone Hydrochloride

41. Troxyca Component Oxycodone Hydrochloride

42. Combunox Component Oxycodone Hydrochloride

43. Oxycodone Hydrochloride Component Of Tylox

44. Percocet Component Oxycodone Hydrochloride

45. Percodan Component Oxycodone Hydrochloride

46. Roxiprin Component Oxycodone Hydrochloride

47. Targiniq Component Oxycodone Hydrochloride

48. Xartemis Component Oxycodone Hydrochloride

49. Oxycodone Hydrochloride Component Of Codoxy

50. Oxycodone Hydrochloride Component Of Oxycet

51. Oxycodone Hydrochloride Component Of Roxicet

52. Oxycodone Hydrochloride Component Of Roxilox

53. Oxycodone Hydrochloride Component Of Troxyca

54. Oxycodone Hydrochloride Component Of Combunox

55. Oxycodone Hydrochloride Component Of Percocet

56. Oxycodone Hydrochloride Component Of Percodan

57. Oxycodone Hydrochloride Component Of Roxiprin

58. Oxycodone Hydrochloride Component Of Targiniq

59. Oxycodone Hydrochloride Component Of Xartemis

60. Percodan-demi Component Oxycodone Hydrochloride

61. Q27107601

62. Oxycodone Hydrochloride Component Of Percodan-demi

63. 14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one Hydrochloride

64. Oxycodone Hydrochloride, European Pharmacopoeia (ep) Reference Standard

65. Oxycodone Hydrochloride, United States Pharmacopeia (usp) Reference Standard

66. (5?)-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

67. (5alpha,17s)-14-hydroxy-3-methoxy-17-methyl-6-oxo-4,5-epoxymorphinan-17-ium Chloride

68. 4,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride

69. Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, Hydrochloride, (5.alpha.)-

70. Oxycodone Hydrochloride Solution, 1.0 Mg/ml In Methanol, Analytical Standard, For Drug Analysis

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 351.8 g/mol
Molecular Formula C18H22ClNO4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count1
Exact Mass351.1237359 g/mol
Monoisotopic Mass351.1237359 g/mol
Topological Polar Surface Area59 Ų
Heavy Atom Count24
Formal Charge0
Complexity553
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameOxecta
Drug LabelOXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active IngredientOxycodone hydrochloride
Dosage FormTablet
RouteOral
Strength7.5mg; 5mg
Market StatusPrescription
CompanyAcura Pharms

2 of 4  
Drug NameOxycodone hydrochloride
Drug LabelDESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active IngredientOxycodone hydrochloride
Dosage FormTablet, extended release; Tablet; Capsule; Solution
Routeoral; Oral
Strength30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market StatusTentative Approval; Prescription
CompanyCorepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

3 of 4  
Drug NameOxecta
Drug LabelOXECTA (oxycodone HCl, USP) tablets are an immediate-release opioid analgesic intended for oral administration only. OXECTA contains oxycodone HCl, USP as the active analgesic ingredient. The tablets are round, convex, white and debossed with the str...
Active IngredientOxycodone hydrochloride
Dosage FormTablet
RouteOral
Strength7.5mg; 5mg
Market StatusPrescription
CompanyAcura Pharms

4 of 4  
Drug NameOxycodone hydrochloride
Drug LabelDESCRIPTIONOxyContin (oxycodone hydrochloride controlled-release) Tablets are an opioid analgesic supplied in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg, and 160 mg tablet strengths for oral administration...
Active IngredientOxycodone hydrochloride
Dosage FormTablet, extended release; Tablet; Capsule; Solution
Routeoral; Oral
Strength30mg; 100mg/5ml; 15mg; 5mg; 10mg; 5mg/5ml; 80mg; 40mg; 20mg
Market StatusTentative Approval; Prescription
CompanyCorepharma; Vintage Pharms; Amneal Pharms; Impax Pharms; Aurolife Pharma; Avanthi; Teva; Endo Pharms; Sun Pharm Inds; Coastal Pharms; Rhodes Pharms; Mallinckrodt; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Lehigh Valley; Alvog

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Analgesics, Opioid

Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)


Narcotics

Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Opioid Agonist [EPC]; Full Opioid Agonists [MoA]

API SUPPLIERS

read-more
read-more

01

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF ROW, CN arrow-down AUDIT
Veranova

02

Parand Darou Pharma

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothParand Darou is a knowledge-based company, focused on the production of Narcotic APIs.

Flag Iran
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Parand Darou Pharma

03

Faran Shimi Pharmaceutical

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Flag Iran
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Faran Shimi Pharmaceutical

04

Temad Co

Iran

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTemad- We think of world-class quality.

Flag Iran
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
Temad

05

EUROAPI

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Flag France
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF CN arrow-down AUDIT
EUROAPI Compnay Banner

06

Rusan Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Rusan Pharma

07

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Noramco

08

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF ROW, CN arrow-down AUDIT
Veranova

09

Veranova

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF arrow-down VMF ROW, CN arrow-down AUDIT
Veranova

10

Noramco

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
PharmaVenue
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT
Noramco
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

arrow
Cosmoprof
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

OXYCODONE HYDROCHLORIDE

NDC Package Code : 49812-0150

Start Marketing Date : 2010-06-01

End Marketing Date : 2024-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Veranova

02

arrow
Cosmoprof
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

OXYCODONE HYDROCHLORIDE

NDC Package Code : 67509-006

Start Marketing Date : 2003-02-03

End Marketing Date : 2026-03-23

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

Noramco

03

Noramco, LLC

U.S.A
arrow
Cosmoprof
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

OXYCODONE

NDC Package Code : 51634-0003

Start Marketing Date : 2008-02-21

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Noramco

04

Noramco, LLC

U.S.A
arrow
Cosmoprof
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNoramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.

Flag U.S.A
Digital Content Digital Content

OXYCODONE HYDROCHLORIDE

NDC Package Code : 51634-0002

Start Marketing Date : 2000-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Noramco

05

Cosmoprof
Not Confirmed
arrow
arrow
Cosmoprof
Not Confirmed

OXYCODONE

NDC Package Code : 69988-0037

Start Marketing Date : 2012-04-02

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/1)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank

06

Cosmoprof
Not Confirmed
arrow
arrow
Cosmoprof
Not Confirmed

OXYCODONE HYDROCHLORIDE

NDC Package Code : 62991-1410

Start Marketing Date : 2011-01-25

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank

07

SpecGx LLC

Ireland
Cosmoprof
Not Confirmed
arrow

SpecGx LLC

Ireland
arrow
Cosmoprof
Not Confirmed

OXYCODONE HYDROCHLORIDE

NDC Package Code : 0406-8853

Start Marketing Date : 2012-12-31

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

SpecGx LLC

Ireland
Cosmoprof
Not Confirmed
arrow

SpecGx LLC

Ireland
arrow
Cosmoprof
Not Confirmed

OXYCODONE HYDROCHLORIDE

NDC Package Code : 0406-8873

Start Marketing Date : 2008-06-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

Medisca Inc.

U.S.A
Cosmoprof
Not Confirmed
arrow

Medisca Inc.

U.S.A
arrow
Cosmoprof
Not Confirmed

OXYCODONE HYDROCHLORIDE

NDC Package Code : 38779-0725

Start Marketing Date : 2014-08-20

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

10

Cosmoprof
Not Confirmed
arrow
arrow
Cosmoprof
Not Confirmed

OXYCODONE HYDROCHLORIDE

NDC Package Code : 51927-1008

Start Marketing Date : 2002-07-19

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714588200,"product":"OXYCODONE HYDROCHLORIDE BASIC DRUG \/ CONTENT 0.495 KG (*FILE NO: XVI\/4\/28\/N\/OXY\/2024)","address":"PLOT NO.58-D,GOVT. INDL.ESTATE,","city":"MUMBAI ,MAHARASHTRA","supplier":"RUSAN PHARMA","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"FSUE MOSCOW ENDOCRINE ","customerCountry":"RUSSIA","quantity":"0.55","actualQuantity":"0.55","unit":"KGS","unitRateFc":"760000","totalValueFC":"5014.7","currency":"INR","unitRateINR":759999.99999999988,"date":"02-May-2024","totalValueINR":"418000","totalValueInUsd":"5014.7","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"9561679","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"PLOT NO.58-D,GOVT. INDL.ESTATE,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672079400,"product":"OXYCODONE HYDROCHLORIDE API-EP-0-0-0","address":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,","city":"NEW DELHI","supplier":"WOOD & COMPANY FINANCIAL SERVICES","supplierCountry":"SLOVAKIA","foreign_port":"NA","customer":"VENOR PHARMA LIMITED","customerCountry":"INDIA","quantity":"0.96","actualQuantity":"0.96","unit":"KGS","unitRateFc":"1426","totalValueFC":"1490.1","currency":"EUR","unitRateINR":"127912.2","date":"27-Dec-2022","totalValueINR":"122795.71","totalValueInUsd":"1490.1","indian_port":"DELHI AIR","hs_no":"29391100","bill_no":"3922566","productDescription":"API","marketType":"REGULATED MARKET","country":"SLOVAK REPUBLIC","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"A-43, GROUND FLOOR G.T.KARNAL ROAD INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734546600,"product":"OXYCODONE HCL USP - 500 GM (OXYCODONE-450 GM)-LOT NO. 2403000348 X 500 GRAMS- AS PER INVOICEOXYCODONE HCL USP - 500 GM (OXYCODONE-450 GM)-LOT NO. 240300","address":"5th FLOOR, 5001-5002, PRERNA AARTIKA,","city":"AHMEDABAD","supplier":"MALLINCKRODT PHARMACEUTICALS","supplierCountry":"UNITED STATES","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"AUXILLA PHARMACEUTICALS AND ","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"3236","totalValueFC":"1631","currency":"USD","unitRateINR":"277163.4","date":"19-Dec-2024","totalValueINR":"138581.7","totalValueInUsd":"1631","indian_port":"Ahmedabad Air","hs_no":"29391100","bill_no":"7342734","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"CHICAGO O\\'HARE INT\\'L","supplierAddress":"3600N SECOND STREET SAINT LOUIS, MO 63147 USA SDNF UNITED STATES","customerAddress":"5th FLOOR, 5001-5002, PRERNA AARTIKA,"}]
27-Dec-2022
19-Dec-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - CAPSULE;ORAL - 5MG

USFDA APPLICATION NUMBER - 200534

read-more

DOSAGE - SOLUTION;ORAL - 100MG/5ML

USFDA APPLICATION NUMBER - 200535

read-more

DOSAGE - SOLUTION;ORAL - 5MG/5ML

USFDA APPLICATION NUMBER - 200535

read-more

DOSAGE - SOLUTION;ORAL - 5MG/5ML

USFDA APPLICATION NUMBER - 201194

read-more

DOSAGE - TABLET;ORAL - 5MG

USFDA APPLICATION NUMBER - 202080

read-more

DOSAGE - TABLET;ORAL - 7.5MG

USFDA APPLICATION NUMBER - 202080

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 325MG;7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 204031

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13....DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 13.5MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 18MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 27MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 36MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 9MG

USFDA APPLICATION NUMBER - 208090

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 10MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 15MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 20MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 30MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 40MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 60MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 80MG

USFDA APPLICATION NUMBER - 22272

read-more

DOSAGE - TABLET;ORAL - 325MG;5MG

USFDA APPLICATION NUMBER - 87003

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Oxycodone Manufacturers

A Oxycodone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxycodone, including repackagers and relabelers. The FDA regulates Oxycodone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxycodone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Oxycodone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Oxycodone Suppliers

A Oxycodone supplier is an individual or a company that provides Oxycodone active pharmaceutical ingredient (API) or Oxycodone finished formulations upon request. The Oxycodone suppliers may include Oxycodone API manufacturers, exporters, distributors and traders.

click here to find a list of Oxycodone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Oxycodone USDMF

A Oxycodone DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxycodone active pharmaceutical ingredient (API) in detail. Different forms of Oxycodone DMFs exist exist since differing nations have different regulations, such as Oxycodone USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Oxycodone DMF submitted to regulatory agencies in the US is known as a USDMF. Oxycodone USDMF includes data on Oxycodone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxycodone USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Oxycodone suppliers with USDMF on PharmaCompass.

Oxycodone JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Oxycodone Drug Master File in Japan (Oxycodone JDMF) empowers Oxycodone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Oxycodone JDMF during the approval evaluation for pharmaceutical products. At the time of Oxycodone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Oxycodone suppliers with JDMF on PharmaCompass.

Oxycodone KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Oxycodone Drug Master File in Korea (Oxycodone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Oxycodone. The MFDS reviews the Oxycodone KDMF as part of the drug registration process and uses the information provided in the Oxycodone KDMF to evaluate the safety and efficacy of the drug.

After submitting a Oxycodone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Oxycodone API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Oxycodone suppliers with KDMF on PharmaCompass.

Oxycodone CEP

A Oxycodone CEP of the European Pharmacopoeia monograph is often referred to as a Oxycodone Certificate of Suitability (COS). The purpose of a Oxycodone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxycodone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxycodone to their clients by showing that a Oxycodone CEP has been issued for it. The manufacturer submits a Oxycodone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxycodone CEP holder for the record. Additionally, the data presented in the Oxycodone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxycodone DMF.

A Oxycodone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxycodone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Oxycodone suppliers with CEP (COS) on PharmaCompass.

Oxycodone WC

A Oxycodone written confirmation (Oxycodone WC) is an official document issued by a regulatory agency to a Oxycodone manufacturer, verifying that the manufacturing facility of a Oxycodone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxycodone APIs or Oxycodone finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxycodone WC (written confirmation) as part of the regulatory process.

click here to find a list of Oxycodone suppliers with Written Confirmation (WC) on PharmaCompass.

Oxycodone NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxycodone as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Oxycodone API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Oxycodone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Oxycodone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxycodone NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Oxycodone suppliers with NDC on PharmaCompass.

Oxycodone GMP

Oxycodone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Oxycodone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxycodone GMP manufacturer or Oxycodone GMP API supplier for your needs.

Oxycodone CoA

A Oxycodone CoA (Certificate of Analysis) is a formal document that attests to Oxycodone's compliance with Oxycodone specifications and serves as a tool for batch-level quality control.

Oxycodone CoA mostly includes findings from lab analyses of a specific batch. For each Oxycodone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Oxycodone may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxycodone EP), Oxycodone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxycodone USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty